Showing results (191-200 of 202) with videos related to
Sort By:
Pageof 21
Blood|April 8, 2025
Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TNJeff P Sharman, Miklos Egyed, Wojciech Jurczak, et al.Blood|January 29, 2021
Natural history of monoclonal B-cell lymphocytosis among relatives in CLL familiesSusan L Slager, Mark C Lanasa, Gerald E Marti, et al.The New England Journal of Medicine|March 26, 2019
Levothyroxine in Women with Thyroid Peroxidase Antibodies before ConceptionRima K Dhillon-Smith, Lee J Middleton, Kirandeep K Sunner, et al.Health Technology Assessment (Winchester, England)|November 25, 2021
Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCTAdam Devall, Justin Chu, Leanne Beeson, et al.Lancet (London, England)|August 28, 2020
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trialJustin J Chu, Adam J Devall, Leanne E Beeson, et al.The New England Journal of Medicine|May 9, 2019
A Randomized Trial of Progesterone in Women with Bleeding in Early PregnancyArri Coomarasamy, Adam J Devall, Versha Cheed, et al.Leukemia|May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelinesMichael Grever, Leslie Andritsos, Versha Banerji, et al.Leukemia & Lymphoma|September 7, 2022
Development of a distributed international patient data registry for hairy cell leukemiaLeslie A Andritsos, Mirela Anghelina, Jasmine Neal, et al.Blood|December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaMichael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.Health Technology Assessment (Winchester, England)|July 2, 2020
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCTArri Coomarasamy, Hoda M Harb, Adam J Devall, et al.Pageof 21